10,000 results
·
96ms
·
Sources: EU EUDAMED, US FDA
279276-2018-CE-IND-NA-PS
Certificate
MDD Annex II Section 4·Sahajanand Medical Technologies Limited·DNV Product Assurance AS·102 Basic UDI-DIs
HU/CA01/54096/13
Certificate
IVDD Annex III Section 6·Biolab Zrt·NEOEMKI Nemzeti Orvostechnikai Eszköz Megfelelőségértékelő és Tanúsító Korlátolt Felelősségű Társaság (NEOEMKI LLC)·1 Basic UDI-DI
HX 1191616-1
Certificate
IVDR QMS·IMMUCOR Medizinische Diagnostik GmbH·TÜV Rheinland LGA Products GmbH
IX 1191616-11
Certificate
IVDR Technical Documentation·IMMUCOR Medizinische Diagnostik GmbH·TÜV Rheinland LGA Products GmbH
HD 2181802-1
Certificate
MDD Annex II (excluding section 4)·Gansu Constar Technology Group Co., Ltd.·TÜV Rheinland LGA Products GmbH·1 Basic UDI-DI
10924233
Certificate
MDD Annex II (excluding section 4)·Gansu Constar Technology Group Co., Ltd.·TÜV Rheinland LGA Products GmbH·1 Basic UDI-DI
HL60145538
Certificate
IVDD Annex IV (excluding sections 4, 6)·GB Lifecare Co., Ltd.·TÜV Rheinland LGA Products GmbH·2 Basic UDI-DIs
Pediatric Esophageal Atresia Anastomosis Device
FDA classification
FDA Class 3
·Pediatric Esophageal Atresia Anastomosis Device
Cyclosporine
FDA Pre-Market Approval
FDA Class 2
·EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION FPSA FLEX REAGENT CARTRIDGE
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·Dimension Vista FPSA Flex reagent cartridge (K6452)
Kit, Assay, Progesterone Receptor
FDA Pre-Market Approval
FDA Class 3
·RIANEN(TM) (3H) PROGESTIN RECEPTOR ASSAY KIT
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·Dimension FPSA Flex Reagent Cartridge
Lens, Contact (Polymethylmethacrylate)
FDA Pre-Market Approval
FDA Unclassified
·PARAPERM O2 CONTACT LENS CLEAR & BLUE
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·Dimension TPSA Flex reagent cartridge (RF451)
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION FPSA FLEX REAGENT CARTRIDGE AND DIMENSION VISTA FPSA FLEX REAGENT CARTRIDGE
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA Pre-Market Approval
FDA Class 3
·DIMENSION VISTA TPSA FLEX REAGENT CARTRIDGE
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION FPSA FLEX REAGENT CARTRIDGE
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·Dimension FPSA Flex reagent cartridge (RF451)
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·Dimension Vista TPSA Flex reagent cartridge (K6451)